Tolemy Bio is a Cambridge and Barcelona-based biotech startup building the virtual-cell intelligence layer for modern biopharma. Founded in 2024 by Alex Ward and Caelan Anderson, the company’s platform, Orbit, combines experimental data, agentic AI and virtual-cell models to help advanced therapy and biologics teams make their cell biology more predictable, interpretable and controllable.
Tolemy Bio
- Life Sciences
- Cambridge, United Kingdom
- £1.2m
- tolemy.bio
- Update Information
More venture news
- 11 May 2026
Tolemy BioTolemy Bio secures a £1.2m pre-seed round led by Norrsken Evolve for software that connects fragmented cell biology data into one workspace
Pre-seedLife Sciences - 5 May 2026
NunaBioNunaBio raises £6.5m led by Northstar Ventures to manufacture high fidelity synthetic DNA at scale
EquityLife Sciences - 5 May 2026
Cytospire TherapeuticsCytospire Therapeutics secures £61m Series A led by 4BIO Capital for cancer therapies that activate the body’s immune cells
Series ALife Sciences
